C. Liebenthal

发表

Immunodepression following neurosurgical procedures.

K. Asadullah, C. Woiciechowsky, H. Volk, 1995, Critical care medicine.

Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure

S. Anker, A. Coats, H. Volk, 2000 .

Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation

M. Plauth, H. Volk, W. Döcke, 2000, Gut.

Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells.

H. Volk, D. Krüger, C. Liebenthal, 1993, The Journal of general virology.

Stimulation of the Human Cytomegalovirus IE Enhancer/Promoter in HL-60 Cells by TNFα Is Mediated via Induction of NF-κB

H. Volk, D. Krüger, C. Liebenthal, 1995 .

Differential regulation of monocytic tumor necrosis factor‐α and interleukin‐10 expression

C. Meisel, H. Volk, F. Randow, 1996, European journal of immunology.

Untersuchungen zur diagnostischen Wertigkeit des Lymphozytentransformationstestes bei Patienten mit Borreliose / Evaluation of the diagnostic significance of the lymphocyte proliferation test in patients with Lyme borreliosis

H. Volk, C. Liebenthal, R. von Baehr, 2007 .

The influence of laparotomy and laparoscopy on tumor growth in a rat model

H. Volk, J. Müller, C. Liebenthal, 1997, Surgical Endoscopy.

Interleukin‐6 and interleukin‐8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation

R. Hetzer, H. Volk, C. Liebenthal, 1994, Critical care medicine.

DARWIN – a next-generation liquid xenon observatory for dark matter and neutrino physics

Tokyo, Ny, The State University of New York, 2021, Proceedings of 37th International Cosmic Ray Conference — PoS(ICRC2021).

Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure

S. Anker, A. Coats, H. Volk, 2000, Circulation.

MONOCYTE DEACTIVATION IN SEPTIC PATIENTS - RESTITUTION BY GCSF TREATMENT

H. Volk, R. Sabat, H. Zuckermann, 1998 .

Immunologic Effector Mechanisms of a Standardized Mistletoe Extract on the Function of Human Monocytes and Lymphocytes in vitro, ex vivo, and in vivo

L. Heinzerling, H. Volk, C. Liebenthal, 2006, Journal of Clinical Immunology.

Inactivation of the very strong HCMV immediate early promoter by DNA CpG methylation in vitro.

H. Volk, D. Krüger, C. Liebenthal, 1996, Biological chemistry Hoppe-Seyler.

The mitogenicity of extracts from Sarcocystis gigantea macrocysts is due to lectin(s)

F. Hiepe, C. Liebenthal, T. Montag, 2004, Parasitology Research.

Proteasome Inhibitors: A Novel Tool to Suppress Human Cytomegalovirus Replication and Virus-Induced Immune Modulation

H. Volk, N. Babel, D. Krüger, 2002, Antiviral therapy.

Improving the in vitro antigen specific T cell proliferation assay: the use of interferon-alpha to elicit antigen specific stimulation and decrease bystander proliferation.

H. Volk, C. Liebenthal, R. von Baehr, 2001, Journal of immunological methods.

Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB.

H. Volk, D. Krüger, C. Liebenthal, 1995, Virology.

[Prophylactic effectiveness of propolis for immunostimulation: a clinical pilot study].

H. Volk, C. Liebenthal, C. Brätter, 1999, Forschende Komplementarmedizin.